{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-111212","form_type":"8-K","ticker":"CTXR","cik":"0001506251","company_name":"Citius Pharmaceuticals, Inc.","filed_at":"2024-12-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.624225+00:00","generated_at":"2026-05-29T00:15:33.188711+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Citius Pharmaceuticals regains Nasdaq compliance on bid price rule","bullets":["Received Nasdaq notice on Dec 18, 2024 confirming compliance with Listing Rule 5550(a)(2).","Stock closed at $1.00 or more for 12 consecutive trading days from Nov 26 to Dec 12, 2024.","Nasdaq stated the matter is now closed."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-111212","json":"https://secwatch.observer/filing/0001213900-24-111212.json","markdown":"https://secwatch.observer/filing/0001213900-24-111212.md","text":"https://secwatch.observer/filing/0001213900-24-111212.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1506251/000121390024111212/0001213900-24-111212-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1506251/000121390024111212/ea0225393-8k_citius.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T00:15:33.188711+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}